SlideShare a Scribd company logo
1 of 29
Genetic Variants of DNA Repair genes and Prostate Cancer:  Department of Epidemiology and Biostatistics  George Washington University  July 2003  A Population-Based Case-Control Study in China Jamie D. Ritchey
Prostate Cancer  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
The Male urinary and reproductive system
International Patterns Hsing, Tsao, and  Devesa, International Journal of Cancer, 2000.  African American men Chinese men in China
Etiology: Risk factors for prostate cancer ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],ACS,  www.acs.gov   2003  NCI,  www.nci.gov  2003
Genetic susceptibility to cancer ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],1Stanford, Epidemiologic Reviews, 2001.  2Greenhut, Kerrigan, and Kelly,  http://press2.nci.nih.gov/sciencebehind/snps_cancer/snps_cancer/snps_  ,  2003.
Single Nucleotide Polymorphisms (SNPs) Greenhut, Kerrigan, and Kelly,  http://press2.nci.nih.gov/sciencebehind/snps_cancer/snps_cancer/snps_  ,  2003. Change in shape Altered Cancer Risk SNP:  Decreased DNA repair  capacity Genomic instability Oncogene activation Inactivate Tumor suppressors Loss of heterozygosity
DNA repair ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Pathway Marker 1 Poirier, 2002  2 Chen, 2001  3 Goode, 2002
DNA Repair Pathways ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Environmental Factors (Diet) + SNP of DNA repair genes = latent effects  increasing  prostate cancer risk ? Greenhut, Kerrigan, and Kelly, http://press2.nci.nih.gov/sciencebehind/snps_ cancer/snps_cancer/snps_  ,  2003.
Shanghai Prostate Cancer Study ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Objectives  ,[object Object],[object Object],[object Object],[object Object],[object Object]
Shanghai Prostate Cancer Study  Study Design 268 Prostate cancer cases Interview 191 Cases  Genotyped  305 controls Genotyped 495 Population  Controls 243 cases  interviewed 472 controls  interviewed 200 cases provided 20 ml fasting blood 330 controls provided 20 ml of fasting blood
Genotyping   Blood Buffy coat Purified DNA MALDI-TOF/hME assays XRCC1_399, XRCC3_241, ERCC2_751, MGMT_84, MGMT_143 191 Cases  Genotyped  305 controls Genotyped
Statistical Analysis ,[object Object]
RESULTS
Selected demographic characteristics Characteristic   Cases   (n=162)  Controls   (n=251) Age < 69 70-75 > 76 Education None Elementary-high College/ above Other Stage Localized Regional Remote Unknown/unstaged PSA % 19 22 20 N 78 89 84 % 15 12 12 N 61 50 51 12 76 12 ~1 29 191 30 1 9 76 15 0 14 124 24 0 - - - - - - - - 38 31 30 1 61 50 48 2
 
Genetic Markers and other Factors:  Combined Effects XRCC1_399 Waist to  Hip Ratio Insulin Resistance Age-Adjusted
Genetic Markers and other Factors:  Combined Effects MGMT_84 Waist to hip  Ratio Insulin  Resistance Age-Adjusted
Genetic Markers and other Factors:  Combined Effects XRCC1_399  Total Preserved Food Age-adjusted
Genetic Markers and other Factors:  Combined Effects MGMT_84  Total Preserved Food
Genetic Markers and other Factors:  Combined Effects XRCC1_399 Allium Vegetable intake
Genetic Markers and other Factors:  Combined Effects MGMT_84 Allium Vegetable intake
Study strengths ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Study limitations ,[object Object],[object Object]
Conclusions ,[object Object],[object Object],[object Object]
Future Research ,[object Object],[object Object],[object Object],[object Object],[object Object]
Acknowledgements ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

More Related Content

What's hot

smoldering myeloma
smoldering myelomasmoldering myeloma
smoldering myelomaspa718
 
Molecular biology of breast cancer [autosaved]
Molecular biology of breast cancer [autosaved]Molecular biology of breast cancer [autosaved]
Molecular biology of breast cancer [autosaved]kamali purushothaman
 
Alphabet Soup - Biomarker testing for colon and rectal cancer patients - KRAS...
Alphabet Soup - Biomarker testing for colon and rectal cancer patients - KRAS...Alphabet Soup - Biomarker testing for colon and rectal cancer patients - KRAS...
Alphabet Soup - Biomarker testing for colon and rectal cancer patients - KRAS...Fight Colorectal Cancer
 
New developments of targeted therapy in nsclc
New developments of targeted therapy in nsclcNew developments of targeted therapy in nsclc
New developments of targeted therapy in nsclclihua jiao
 
Ohio State's 2016 ASH Review T-cell Disorders
Ohio State's 2016 ASH Review T-cell DisordersOhio State's 2016 ASH Review T-cell Disorders
Ohio State's 2016 ASH Review T-cell DisordersOSUCCC - James
 
Ohio State's 2016 ASH Review - ASH Review 2015 Acute Leukemias and MDS
Ohio State's 2016 ASH Review - ASH Review 2015Acute Leukemias and MDSOhio State's 2016 ASH Review - ASH Review 2015Acute Leukemias and MDS
Ohio State's 2016 ASH Review - ASH Review 2015 Acute Leukemias and MDSOSUCCC - James
 
MCO 2011 - Slide 9 - G. Curigliano - Joint medics and nurses spotlight sessio...
MCO 2011 - Slide 9 - G. Curigliano - Joint medics and nurses spotlight sessio...MCO 2011 - Slide 9 - G. Curigliano - Joint medics and nurses spotlight sessio...
MCO 2011 - Slide 9 - G. Curigliano - Joint medics and nurses spotlight sessio...European School of Oncology
 
Web cast cancer gene panels march 11 2015
Web cast cancer gene panels march 11 2015Web cast cancer gene panels march 11 2015
Web cast cancer gene panels march 11 2015Andreas Scherer
 
Management of metastatic colorectal cancer
Management of metastatic colorectal cancerManagement of metastatic colorectal cancer
Management of metastatic colorectal cancerMohamed Abdulla
 
ANGIOGENESIS AND CANCER TREATMENTS
ANGIOGENESIS AND CANCER TREATMENTSANGIOGENESIS AND CANCER TREATMENTS
ANGIOGENESIS AND CANCER TREATMENTSindranil chatterjee
 
donor selection in Haplo Transplant
donor selection in Haplo Transplantdonor selection in Haplo Transplant
donor selection in Haplo Transplantspa718
 
Mmp Rev J Biomed Sc 2010
Mmp  Rev J Biomed Sc 2010Mmp  Rev J Biomed Sc 2010
Mmp Rev J Biomed Sc 2010rm8509
 
Clinical Genomics for Personalized Cancer Medicine: Recent Advances, Challeng...
Clinical Genomics for Personalized Cancer Medicine: Recent Advances, Challeng...Clinical Genomics for Personalized Cancer Medicine: Recent Advances, Challeng...
Clinical Genomics for Personalized Cancer Medicine: Recent Advances, Challeng...Yoon Sup Choi
 
Ohio State's 2016 ASH Review - BEST OF ASH 2015 MULTIPLE MYELOMA AND PLASMA C...
Ohio State's 2016 ASH Review - BEST OF ASH 2015 MULTIPLE MYELOMA AND PLASMA C...Ohio State's 2016 ASH Review - BEST OF ASH 2015 MULTIPLE MYELOMA AND PLASMA C...
Ohio State's 2016 ASH Review - BEST OF ASH 2015 MULTIPLE MYELOMA AND PLASMA C...OSUCCC - James
 
Oliva esther aml eurasian st. petersburg 2016
Oliva esther  aml eurasian st. petersburg 2016Oliva esther  aml eurasian st. petersburg 2016
Oliva esther aml eurasian st. petersburg 2016EAFO2014
 

What's hot (20)

smoldering myeloma
smoldering myelomasmoldering myeloma
smoldering myeloma
 
Molecular biology of breast cancer [autosaved]
Molecular biology of breast cancer [autosaved]Molecular biology of breast cancer [autosaved]
Molecular biology of breast cancer [autosaved]
 
Alphabet Soup - Biomarker testing for colon and rectal cancer patients - KRAS...
Alphabet Soup - Biomarker testing for colon and rectal cancer patients - KRAS...Alphabet Soup - Biomarker testing for colon and rectal cancer patients - KRAS...
Alphabet Soup - Biomarker testing for colon and rectal cancer patients - KRAS...
 
G. Ceresoli - Lung cancer - State of the art
G. Ceresoli - Lung cancer - State of the artG. Ceresoli - Lung cancer - State of the art
G. Ceresoli - Lung cancer - State of the art
 
New developments of targeted therapy in nsclc
New developments of targeted therapy in nsclcNew developments of targeted therapy in nsclc
New developments of targeted therapy in nsclc
 
Cancer lecture
Cancer lectureCancer lecture
Cancer lecture
 
Ohio State's 2016 ASH Review T-cell Disorders
Ohio State's 2016 ASH Review T-cell DisordersOhio State's 2016 ASH Review T-cell Disorders
Ohio State's 2016 ASH Review T-cell Disorders
 
Ohio State's 2016 ASH Review - ASH Review 2015 Acute Leukemias and MDS
Ohio State's 2016 ASH Review - ASH Review 2015Acute Leukemias and MDSOhio State's 2016 ASH Review - ASH Review 2015Acute Leukemias and MDS
Ohio State's 2016 ASH Review - ASH Review 2015 Acute Leukemias and MDS
 
MCO 2011 - Slide 9 - G. Curigliano - Joint medics and nurses spotlight sessio...
MCO 2011 - Slide 9 - G. Curigliano - Joint medics and nurses spotlight sessio...MCO 2011 - Slide 9 - G. Curigliano - Joint medics and nurses spotlight sessio...
MCO 2011 - Slide 9 - G. Curigliano - Joint medics and nurses spotlight sessio...
 
Web cast cancer gene panels march 11 2015
Web cast cancer gene panels march 11 2015Web cast cancer gene panels march 11 2015
Web cast cancer gene panels march 11 2015
 
Management of metastatic colorectal cancer
Management of metastatic colorectal cancerManagement of metastatic colorectal cancer
Management of metastatic colorectal cancer
 
ANGIOGENESIS AND CANCER TREATMENTS
ANGIOGENESIS AND CANCER TREATMENTSANGIOGENESIS AND CANCER TREATMENTS
ANGIOGENESIS AND CANCER TREATMENTS
 
donor selection in Haplo Transplant
donor selection in Haplo Transplantdonor selection in Haplo Transplant
donor selection in Haplo Transplant
 
ACC Cancer Cell May 2016
ACC Cancer Cell May 2016ACC Cancer Cell May 2016
ACC Cancer Cell May 2016
 
Mmp Rev J Biomed Sc 2010
Mmp  Rev J Biomed Sc 2010Mmp  Rev J Biomed Sc 2010
Mmp Rev J Biomed Sc 2010
 
Clinical Genomics for Personalized Cancer Medicine: Recent Advances, Challeng...
Clinical Genomics for Personalized Cancer Medicine: Recent Advances, Challeng...Clinical Genomics for Personalized Cancer Medicine: Recent Advances, Challeng...
Clinical Genomics for Personalized Cancer Medicine: Recent Advances, Challeng...
 
Tnbc 2018 update
Tnbc 2018 updateTnbc 2018 update
Tnbc 2018 update
 
Ohio State's 2016 ASH Review - BEST OF ASH 2015 MULTIPLE MYELOMA AND PLASMA C...
Ohio State's 2016 ASH Review - BEST OF ASH 2015 MULTIPLE MYELOMA AND PLASMA C...Ohio State's 2016 ASH Review - BEST OF ASH 2015 MULTIPLE MYELOMA AND PLASMA C...
Ohio State's 2016 ASH Review - BEST OF ASH 2015 MULTIPLE MYELOMA AND PLASMA C...
 
Oliva esther aml eurasian st. petersburg 2016
Oliva esther  aml eurasian st. petersburg 2016Oliva esther  aml eurasian st. petersburg 2016
Oliva esther aml eurasian st. petersburg 2016
 
E112431
E112431E112431
E112431
 

Viewers also liked

Reducing the burden of prostate cancer
Reducing the burden of prostate cancerReducing the burden of prostate cancer
Reducing the burden of prostate cancerMarc Laniado
 
Evaluation of the Oncotype DX Risk - Pilot Project Update 2016
Evaluation of the Oncotype DX Risk - Pilot Project Update 2016Evaluation of the Oncotype DX Risk - Pilot Project Update 2016
Evaluation of the Oncotype DX Risk - Pilot Project Update 2016libbe019
 
Intern talk prostate and testis cancer 2015
Intern talk prostate and testis cancer 2015Intern talk prostate and testis cancer 2015
Intern talk prostate and testis cancer 2015katejohnpunag
 
Management of advanced prostate carcinoma
Management of advanced prostate carcinomaManagement of advanced prostate carcinoma
Management of advanced prostate carcinomaAsi-oqua Bassey
 
Overview and Pharmacotherapy of Prostate Cancer (based on NCCN 2012 guideline...
Overview and Pharmacotherapy of Prostate Cancer (based on NCCN 2012 guideline...Overview and Pharmacotherapy of Prostate Cancer (based on NCCN 2012 guideline...
Overview and Pharmacotherapy of Prostate Cancer (based on NCCN 2012 guideline...hyunik116
 
The Human Genome Project - Part III
The Human Genome Project - Part IIIThe Human Genome Project - Part III
The Human Genome Project - Part IIIhhalhaddad
 
Prostate Cancer: Causes, Diagnosis, and Treatment Options Bruce B ... Prost...
Prostate Cancer: Causes, Diagnosis, and Treatment Options Bruce B ... 	 Prost...Prostate Cancer: Causes, Diagnosis, and Treatment Options Bruce B ... 	 Prost...
Prostate Cancer: Causes, Diagnosis, and Treatment Options Bruce B ... Prost...MedicineAndHealthCancer
 
Cervical Cancer Educational Presentation
Cervical Cancer Educational PresentationCervical Cancer Educational Presentation
Cervical Cancer Educational Presentationrinki singh
 

Viewers also liked (10)

Reducing the burden of prostate cancer
Reducing the burden of prostate cancerReducing the burden of prostate cancer
Reducing the burden of prostate cancer
 
Evaluation of the Oncotype DX Risk - Pilot Project Update 2016
Evaluation of the Oncotype DX Risk - Pilot Project Update 2016Evaluation of the Oncotype DX Risk - Pilot Project Update 2016
Evaluation of the Oncotype DX Risk - Pilot Project Update 2016
 
Analysis of high grade prostate cancer microarray data
Analysis of high grade prostate cancer microarray dataAnalysis of high grade prostate cancer microarray data
Analysis of high grade prostate cancer microarray data
 
Dna presentation
Dna presentationDna presentation
Dna presentation
 
Intern talk prostate and testis cancer 2015
Intern talk prostate and testis cancer 2015Intern talk prostate and testis cancer 2015
Intern talk prostate and testis cancer 2015
 
Management of advanced prostate carcinoma
Management of advanced prostate carcinomaManagement of advanced prostate carcinoma
Management of advanced prostate carcinoma
 
Overview and Pharmacotherapy of Prostate Cancer (based on NCCN 2012 guideline...
Overview and Pharmacotherapy of Prostate Cancer (based on NCCN 2012 guideline...Overview and Pharmacotherapy of Prostate Cancer (based on NCCN 2012 guideline...
Overview and Pharmacotherapy of Prostate Cancer (based on NCCN 2012 guideline...
 
The Human Genome Project - Part III
The Human Genome Project - Part IIIThe Human Genome Project - Part III
The Human Genome Project - Part III
 
Prostate Cancer: Causes, Diagnosis, and Treatment Options Bruce B ... Prost...
Prostate Cancer: Causes, Diagnosis, and Treatment Options Bruce B ... 	 Prost...Prostate Cancer: Causes, Diagnosis, and Treatment Options Bruce B ... 	 Prost...
Prostate Cancer: Causes, Diagnosis, and Treatment Options Bruce B ... Prost...
 
Cervical Cancer Educational Presentation
Cervical Cancer Educational PresentationCervical Cancer Educational Presentation
Cervical Cancer Educational Presentation
 

Similar to DNA repair and prostate cancer

Proteogenomic analysis of human colon cancer reveals new therapeutic opportun...
Proteogenomic analysis of human colon cancer reveals new therapeutic opportun...Proteogenomic analysis of human colon cancer reveals new therapeutic opportun...
Proteogenomic analysis of human colon cancer reveals new therapeutic opportun...Gul Muneer
 
NY Prostate Cancer Conference - S. Stone - Session 1: Cell cycle progression ...
NY Prostate Cancer Conference - S. Stone - Session 1: Cell cycle progression ...NY Prostate Cancer Conference - S. Stone - Session 1: Cell cycle progression ...
NY Prostate Cancer Conference - S. Stone - Session 1: Cell cycle progression ...European School of Oncology
 
Unit Presentation Dec 08 Short
Unit Presentation Dec 08 ShortUnit Presentation Dec 08 Short
Unit Presentation Dec 08 ShortGilesOElliott
 
QMB_Poster_Tom_Kelly
QMB_Poster_Tom_KellyQMB_Poster_Tom_Kelly
QMB_Poster_Tom_KellyTom Kelly
 
Understanding Uterine Cancer Treatment Options
Understanding Uterine Cancer Treatment OptionsUnderstanding Uterine Cancer Treatment Options
Understanding Uterine Cancer Treatment Optionsbkling
 
hMSH2 Gly322Asp (rs4987188) Single nucleotide polymorphism and the risk of br...
hMSH2 Gly322Asp (rs4987188) Single nucleotide polymorphism and the risk of br...hMSH2 Gly322Asp (rs4987188) Single nucleotide polymorphism and the risk of br...
hMSH2 Gly322Asp (rs4987188) Single nucleotide polymorphism and the risk of br...Agriculture Journal IJOEAR
 
MCO 2011 - Slide 33 - C. Svedman - Spotlight session - Criteria to evaluate g...
MCO 2011 - Slide 33 - C. Svedman - Spotlight session - Criteria to evaluate g...MCO 2011 - Slide 33 - C. Svedman - Spotlight session - Criteria to evaluate g...
MCO 2011 - Slide 33 - C. Svedman - Spotlight session - Criteria to evaluate g...European School of Oncology
 
헬스케어 빅데이터로 무엇을 할 수 있는가?
헬스케어 빅데이터로 무엇을 할 수 있는가?헬스케어 빅데이터로 무엇을 할 수 있는가?
헬스케어 빅데이터로 무엇을 할 수 있는가? Hyung Jin Choi
 
Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...
Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...
Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...semualkaira
 
LLA 2011 - B. Cheson - Problems of the design and interpretation of very earl...
LLA 2011 - B. Cheson - Problems of the design and interpretation of very earl...LLA 2011 - B. Cheson - Problems of the design and interpretation of very earl...
LLA 2011 - B. Cheson - Problems of the design and interpretation of very earl...European School of Oncology
 
Transcriptome Analysis of Spontaneous PDF
Transcriptome Analysis of Spontaneous PDFTranscriptome Analysis of Spontaneous PDF
Transcriptome Analysis of Spontaneous PDFJanaya Shelly
 
Personalized vs. Precision, let’s call it Medicine
Personalized vs. Precision, let’s call it MedicinePersonalized vs. Precision, let’s call it Medicine
Personalized vs. Precision, let’s call it Medicineflasco_org
 
Assessing the clinical utility of cancer genomic and proteomic data across tu...
Assessing the clinical utility of cancer genomic and proteomic data across tu...Assessing the clinical utility of cancer genomic and proteomic data across tu...
Assessing the clinical utility of cancer genomic and proteomic data across tu...Gul Muneer
 

Similar to DNA repair and prostate cancer (20)

Proteogenomic analysis of human colon cancer reveals new therapeutic opportun...
Proteogenomic analysis of human colon cancer reveals new therapeutic opportun...Proteogenomic analysis of human colon cancer reveals new therapeutic opportun...
Proteogenomic analysis of human colon cancer reveals new therapeutic opportun...
 
NY Prostate Cancer Conference - S. Stone - Session 1: Cell cycle progression ...
NY Prostate Cancer Conference - S. Stone - Session 1: Cell cycle progression ...NY Prostate Cancer Conference - S. Stone - Session 1: Cell cycle progression ...
NY Prostate Cancer Conference - S. Stone - Session 1: Cell cycle progression ...
 
Unit Presentation Dec 08 Short
Unit Presentation Dec 08 ShortUnit Presentation Dec 08 Short
Unit Presentation Dec 08 Short
 
QMB_Poster_Tom_Kelly
QMB_Poster_Tom_KellyQMB_Poster_Tom_Kelly
QMB_Poster_Tom_Kelly
 
Understanding Uterine Cancer Treatment Options
Understanding Uterine Cancer Treatment OptionsUnderstanding Uterine Cancer Treatment Options
Understanding Uterine Cancer Treatment Options
 
Pharmacogenomic presentation medication saftey 110417 final2
Pharmacogenomic presentation  medication saftey 110417 final2Pharmacogenomic presentation  medication saftey 110417 final2
Pharmacogenomic presentation medication saftey 110417 final2
 
hMSH2 Gly322Asp (rs4987188) Single nucleotide polymorphism and the risk of br...
hMSH2 Gly322Asp (rs4987188) Single nucleotide polymorphism and the risk of br...hMSH2 Gly322Asp (rs4987188) Single nucleotide polymorphism and the risk of br...
hMSH2 Gly322Asp (rs4987188) Single nucleotide polymorphism and the risk of br...
 
MCO 2011 - Slide 33 - C. Svedman - Spotlight session - Criteria to evaluate g...
MCO 2011 - Slide 33 - C. Svedman - Spotlight session - Criteria to evaluate g...MCO 2011 - Slide 33 - C. Svedman - Spotlight session - Criteria to evaluate g...
MCO 2011 - Slide 33 - C. Svedman - Spotlight session - Criteria to evaluate g...
 
헬스케어 빅데이터로 무엇을 할 수 있는가?
헬스케어 빅데이터로 무엇을 할 수 있는가?헬스케어 빅데이터로 무엇을 할 수 있는가?
헬스케어 빅데이터로 무엇을 할 수 있는가?
 
Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...
Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...
Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...
 
LLA 2011 - B. Cheson - Problems of the design and interpretation of very earl...
LLA 2011 - B. Cheson - Problems of the design and interpretation of very earl...LLA 2011 - B. Cheson - Problems of the design and interpretation of very earl...
LLA 2011 - B. Cheson - Problems of the design and interpretation of very earl...
 
4625.full
4625.full4625.full
4625.full
 
4625.full
4625.full4625.full
4625.full
 
Transcriptome Analysis of Spontaneous PDF
Transcriptome Analysis of Spontaneous PDFTranscriptome Analysis of Spontaneous PDF
Transcriptome Analysis of Spontaneous PDF
 
5.16.11 biomarkers and genetic tests
5.16.11 biomarkers and genetic tests5.16.11 biomarkers and genetic tests
5.16.11 biomarkers and genetic tests
 
5.16.11 biomarkers and genetic tests
5.16.11 biomarkers and genetic tests5.16.11 biomarkers and genetic tests
5.16.11 biomarkers and genetic tests
 
Genome wide study
Genome wide studyGenome wide study
Genome wide study
 
Personalized vs. Precision, let’s call it Medicine
Personalized vs. Precision, let’s call it MedicinePersonalized vs. Precision, let’s call it Medicine
Personalized vs. Precision, let’s call it Medicine
 
Oral cancer ,field cancerization dr mnr
Oral cancer ,field cancerization dr mnrOral cancer ,field cancerization dr mnr
Oral cancer ,field cancerization dr mnr
 
Assessing the clinical utility of cancer genomic and proteomic data across tu...
Assessing the clinical utility of cancer genomic and proteomic data across tu...Assessing the clinical utility of cancer genomic and proteomic data across tu...
Assessing the clinical utility of cancer genomic and proteomic data across tu...
 

More from jamieritchey

Annual Arizona Conference for Tribal BCCEDP Collaboration, Flagstaff, AZ
Annual Arizona Conference for Tribal BCCEDP Collaboration, Flagstaff, AZAnnual Arizona Conference for Tribal BCCEDP Collaboration, Flagstaff, AZ
Annual Arizona Conference for Tribal BCCEDP Collaboration, Flagstaff, AZjamieritchey
 
(4) Southwest American Indian Cancer Network, Cancer Epidemiology Presentatio...
(4)	Southwest American Indian Cancer Network, Cancer Epidemiology Presentatio...(4)	Southwest American Indian Cancer Network, Cancer Epidemiology Presentatio...
(4) Southwest American Indian Cancer Network, Cancer Epidemiology Presentatio...jamieritchey
 
University of Arizona School of Public Health Seminar
University of Arizona School of Public Health SeminarUniversity of Arizona School of Public Health Seminar
University of Arizona School of Public Health Seminarjamieritchey
 
Poster Slide Final
Poster Slide FinalPoster Slide Final
Poster Slide Finaljamieritchey
 
Koch To Quantiferon
Koch To QuantiferonKoch To Quantiferon
Koch To Quantiferonjamieritchey
 
Hepatocellular Carcinoma (Hcc)
Hepatocellular Carcinoma (Hcc)Hepatocellular Carcinoma (Hcc)
Hepatocellular Carcinoma (Hcc)jamieritchey
 
Prostate Cancer Quality Of Care
Prostate Cancer Quality Of CareProstate Cancer Quality Of Care
Prostate Cancer Quality Of Carejamieritchey
 
Prostate Cancer in Africa, NCI Summer Fellowship
Prostate Cancer in Africa, NCI Summer FellowshipProstate Cancer in Africa, NCI Summer Fellowship
Prostate Cancer in Africa, NCI Summer Fellowshipjamieritchey
 

More from jamieritchey (9)

Annual Arizona Conference for Tribal BCCEDP Collaboration, Flagstaff, AZ
Annual Arizona Conference for Tribal BCCEDP Collaboration, Flagstaff, AZAnnual Arizona Conference for Tribal BCCEDP Collaboration, Flagstaff, AZ
Annual Arizona Conference for Tribal BCCEDP Collaboration, Flagstaff, AZ
 
(4) Southwest American Indian Cancer Network, Cancer Epidemiology Presentatio...
(4)	Southwest American Indian Cancer Network, Cancer Epidemiology Presentatio...(4)	Southwest American Indian Cancer Network, Cancer Epidemiology Presentatio...
(4) Southwest American Indian Cancer Network, Cancer Epidemiology Presentatio...
 
University of Arizona School of Public Health Seminar
University of Arizona School of Public Health SeminarUniversity of Arizona School of Public Health Seminar
University of Arizona School of Public Health Seminar
 
APHA Nov 2011
APHA Nov 2011APHA Nov 2011
APHA Nov 2011
 
Poster Slide Final
Poster Slide FinalPoster Slide Final
Poster Slide Final
 
Koch To Quantiferon
Koch To QuantiferonKoch To Quantiferon
Koch To Quantiferon
 
Hepatocellular Carcinoma (Hcc)
Hepatocellular Carcinoma (Hcc)Hepatocellular Carcinoma (Hcc)
Hepatocellular Carcinoma (Hcc)
 
Prostate Cancer Quality Of Care
Prostate Cancer Quality Of CareProstate Cancer Quality Of Care
Prostate Cancer Quality Of Care
 
Prostate Cancer in Africa, NCI Summer Fellowship
Prostate Cancer in Africa, NCI Summer FellowshipProstate Cancer in Africa, NCI Summer Fellowship
Prostate Cancer in Africa, NCI Summer Fellowship
 

DNA repair and prostate cancer

  • 1. Genetic Variants of DNA Repair genes and Prostate Cancer: Department of Epidemiology and Biostatistics George Washington University July 2003 A Population-Based Case-Control Study in China Jamie D. Ritchey
  • 2.
  • 3. The Male urinary and reproductive system
  • 4. International Patterns Hsing, Tsao, and Devesa, International Journal of Cancer, 2000. African American men Chinese men in China
  • 5.
  • 6.
  • 7. Single Nucleotide Polymorphisms (SNPs) Greenhut, Kerrigan, and Kelly, http://press2.nci.nih.gov/sciencebehind/snps_cancer/snps_cancer/snps_ , 2003. Change in shape Altered Cancer Risk SNP: Decreased DNA repair capacity Genomic instability Oncogene activation Inactivate Tumor suppressors Loss of heterozygosity
  • 8.
  • 9.
  • 10. Environmental Factors (Diet) + SNP of DNA repair genes = latent effects increasing prostate cancer risk ? Greenhut, Kerrigan, and Kelly, http://press2.nci.nih.gov/sciencebehind/snps_ cancer/snps_cancer/snps_ , 2003.
  • 11.
  • 12.
  • 13. Shanghai Prostate Cancer Study Study Design 268 Prostate cancer cases Interview 191 Cases Genotyped 305 controls Genotyped 495 Population Controls 243 cases interviewed 472 controls interviewed 200 cases provided 20 ml fasting blood 330 controls provided 20 ml of fasting blood
  • 14. Genotyping Blood Buffy coat Purified DNA MALDI-TOF/hME assays XRCC1_399, XRCC3_241, ERCC2_751, MGMT_84, MGMT_143 191 Cases Genotyped 305 controls Genotyped
  • 15.
  • 17. Selected demographic characteristics Characteristic Cases (n=162) Controls (n=251) Age < 69 70-75 > 76 Education None Elementary-high College/ above Other Stage Localized Regional Remote Unknown/unstaged PSA % 19 22 20 N 78 89 84 % 15 12 12 N 61 50 51 12 76 12 ~1 29 191 30 1 9 76 15 0 14 124 24 0 - - - - - - - - 38 31 30 1 61 50 48 2
  • 18.  
  • 19. Genetic Markers and other Factors: Combined Effects XRCC1_399 Waist to Hip Ratio Insulin Resistance Age-Adjusted
  • 20. Genetic Markers and other Factors: Combined Effects MGMT_84 Waist to hip Ratio Insulin Resistance Age-Adjusted
  • 21. Genetic Markers and other Factors: Combined Effects XRCC1_399 Total Preserved Food Age-adjusted
  • 22. Genetic Markers and other Factors: Combined Effects MGMT_84 Total Preserved Food
  • 23. Genetic Markers and other Factors: Combined Effects XRCC1_399 Allium Vegetable intake
  • 24. Genetic Markers and other Factors: Combined Effects MGMT_84 Allium Vegetable intake
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.

Editor's Notes

  1. Good morning. I will be talking about DNA repair variants and prostate cancer, presenting results from a recent population-based case-control study in Shanghai, China in which I investigated the data for the GWU Special project requirement.